## Note
nid: 1554282956617
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step1_v11::#OME_banner::Clinical::05_Hematology_Oncology::05_Leukemia, #AK_Step1_v11::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::03_Polycythemia, #AK_Step2_v11::!FLAG_THESE_CARDS::!DELETE, #AK_Step2_v11::!Shelf::IM, #AK_Step2_v11::#OME::05_Heme_Onc::05_Leukemia, #AK_Step2_v11::#Resources_by_rotation::IM::ome::heme/onc::leukemia, #AK_Step2_v11::#Subjects::Hematology::03_WBC::04_Myeloproliferative_Disorders::*Basics, #AK_Step2_v11::Original_decks::Dorian::im::ome::heme/onc::leukemia
markdown: false

### Text
<div>
  <b>Chronic myeloproliferative disorders</b> (<u>except CML</u>)
  are associated with <b>{{c1::</b>V617F <b><i>JAK2</i>}} mutations
  -</b> the mutation is in a gene encoding a(n) {{c2::tyrosine
  kinase::enzyme}}, which causes tyrosine
  <u>hyperphosphorylation</u> and <u>hypersensitivity of progenitor
  cells to cytokines</u>, prolonging cellular growth
</div>

### Extra
<div>
  <b>JAK2:</b> is a tyrosine kinase - mutation causes tyrosine
  hyperphosphorylation and hypersensitivity to cytokines = more
  growth/survival
</div>
<div><img src="paste-6657315272916993.jpg"></div>
<div><img src="paste-1269957404917763.jpg"></div><img src=
"paste-5489930276962305.jpg">

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy
<div><img src="PV%20JAK2%20V617F_1566160514431.jpg"><img src=
"Zoverall%20picture%20(81)_1566160514431.JPG"></div>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/hematology-oncology/leukemia/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_1.png"></a>
</div>

### Additional Resources


### One by one

